66 patients, 73% of the total number of patients that received end-of-life care until their demise, were treated with medicines to maintain a superficial sedation.
A 66 pacientes, el 73% de los atendidos hasta el final de la vida, se les administraron medicamentos para obtener una sedación superficial.